ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 391

Self-Assessment Tool of Rheumatoid Arthritis Disease Activity: Handgrip Strength Measured By a Smartphone Connected to a Dynamometer

Francisco Espinoza Sr.1, Yves-marie Pers Sr.2, Pierre LeBlay Sr.2 and Christian Jorgensen2, 1Rheumatology Department, Division of Internal Medicine, School of Medicine, University of Los Andes, Santiago, Chile, 2Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHU Lapeyronie., Montpellier, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose

Patient self-management should become a key component of rheumatology care. Development of modalities using personal technologies resources represents an attractive way to assess periodic disease’s activity. We previously developed a Smartphone application and a software to measure the dominant handgrip strength in rheumatoid arthritis (RA) patients. This pilot-study was performed in healthy and RA volunteers for testing and calibrating the system with a classical dynamometer. Then using this novel handheld device, we conducted an exploratory study to correlate RA disease activity with handgrip strength. Here we present our preliminary results.

Methods

We included 50 patients with RA. All patients fulfilled the 2010 ACR/EULAR criteria for RA. We excluded patients with health issues that could affect the test (hand or wrist surgery, myopathy, carpal tunnel syndrome, etc). Patients received visual and audio instructions from the Smartphone application and one-trained operator was present. The 28-joint disease activity score (DAS28) and modified Health Assessment Questionnaire (mHAQ) were measured for all participants. Linear regression and Two-Way ANOVA test were performed. The results were adjusted by age and sex

Results

96% of patients were females. Mean age was 62,59 + 12,9. Mean DAS28 was 3,41 ± 1,38 and 38% of patients were in remission (DAS28<2,6). 22% were treated with Methotrexate or Leflunomide and 76% were treated with a bDMARD in association or not with a sDMARD. No patients reported difficulties or pain performing the test. Mean duration of the test was 3.5 minutes ± 0.22 and handgrip strength level was 9,63 ± 5,49 Kg. A significantly negative correlation between the index of handgrip strength test and DAS28 was identified (r=-0.79,-0.85 to -0.34, p<0,01). We observed a significant correlation with the mHAQ (r=0.85, 0,67 to 0,96, p<0,01). In a subgroup of 15 patients we evaluated the handgrip strength after treatment modifications or disease flare-up exacerbations and we founded a significantly correlation with DAS28 changes (r=-0.93, -0.76 to -0.54, p<0.001). Ultimately we observed a tendency to correlate index of handgrip strength, adjusted by age and sex, and the presence of ultrasonography synovitis in a subgroup of 10 patients (p=0.076)

Conclusion

Our preliminary data showed that Smartphone self-evaluation of handgrip strength is a feasible way to assess RA disease activity. Moreover, we will continue to follow longitudinally our RA patients in order to determinate if this test could be used to detect flare-up or response to treatment. Then, we will validate this simple tool of self-assessment RA activity in a larger outpatients cohort


Disclosure:

F. Espinoza Sr.,
None;

Y. M. Pers Sr.,
None;

P. LeBlay Sr.,
None;

C. Jorgensen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-assessment-tool-of-rheumatoid-arthritis-disease-activity-handgrip-strength-measured-by-a-smartphone-connected-to-a-dynamometer/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology